# Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

> **NCT00439244** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 412 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Zoledronic acid
- **DRUG:** Placebo
- **DRUG:** Teriparatide

## Key facts

- **NCT ID:** NCT00439244
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2011-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00439244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00439244, "Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00439244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*